Hospital Medicine

Albumin infusions did not result in statistically significant differences in predefined study endpoints.

Researchers see differences in how SARS-CoV-2 attacks the brain in comparison to the influenza virus that caused the 1918 pandemic.

The FDA recently issued the third EUA for a COVID-19 vaccine in the US.

Surveyed patients discharged from the hospital are reporting respiratory burdens beyond 6 months. Are outpatient facilities equipped to manage COVID-19 long haulers?

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

In data presented during AAAAI 21, researchers compared the 2006 and 2016 versions of the diagnostic criteria proposed by the NIAD/FAAN.

All patients in the study who tested positive for COVID-19 suffered from mild or moderate symptoms.

“A high or rising white blood cell count in isolation is not a sufficient indication for C diff infection testing,” the study authors said.

The injection bags will be available in 1000 mg in 100 mL doses, as well as in 500 mg in 50 mL doses.

The findings should assuage concerns about small intestinal bacterial overgrowth when prescribing treatment with proton pump inhibitors.

Nonanastomotic biliary strictures occurred in 6% of the patients in the machine-perfusion group, while the complication occurred in 18% of the control group.

The Ad26 platform has been used in vaccines administered to nearly 200,000 real-world and clinical trial participants

Mediterranean region imposes partial lockdown following a surge in cases.

Approximately 13.8 million doses of COVID-19 vaccines have been administered during a 1 month period.

Missed diagnosis resulted in delays in initiation of therapy and hospital re-admissions.

The 3D-printed implant is patient specific and modeled after the anatomy of the individual.

Vitamin D supplements did not change the biochemical markers significantly for hepatitis C patients with vitamin D insufficiencies.

No approved treatment for leber hereditary optic neuropathy is currently available in the United States.

The FDA gives Moderna the green light to increase vaccine vials by 40%.

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

Investigators conclude improvements in kidney transplantation may require significant interventions.

In results from a phase 2 trial show 7.5gm of DAV132 administered three times daily demonstrated protection against antibiotic-induced disruption of intestinal microbiota.

Patients with 3 or more C diff recurrences also had the highest health care resources utilization and total, all-cause, direct medical costs.

Linaclotide has been marketed as LINZESS to treat irritable bowel syndrome with constipation.

Two pediatric cardiologists offer perspective on how to approach conversations about MIS-C with parents or guardians.